Marrone Bio Innovations, Inc. (MBII) financial statements (2021 and earlier)

Company profile

Business Address 1540 DREW AVENUE
DAVIS, CA 95618
State of Incorp. DE
Fiscal Year End December 31
SIC 287 - Agricultural Chemicals (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments618110203538
Cash and cash equivalents618110203524
Short-term investments      14
Restricted cash and investments  0122 
Receivables6344226
Inventory, net of allowances, customer advances and progress billings8810891312
Inventory8810891312
Deferred costs    000
Other undisclosed current assets1144332
Total current assets:22301927365559
Noncurrent Assets
Operating lease, right-of-use asset5
Property, plant and equipment1315161718209
Intangible assets, net (including goodwill)31     
Goodwill7      
Intangible assets, net (excluding goodwill)24      
Restricted cash and investments2222172 
Deferred costs     00
Other noncurrent assets1000111
Other undisclosed noncurrent assets     (0)(0)
Total noncurrent assets:51161819362210
TOTAL ASSETS:73473746727769
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities16912781411
Accounts payable3241264
Accrued liabilities12786664
Employee-related liabilities     12
Deferred revenue0
Debt42211142
Customer refund liability     1 
Deferred revenue and credits66331
Other undisclosed current liabilities10221(1)(2)
Total current liabilities:21112215133112
Noncurrent Liabilities
Long-term debt and lease obligation16122421221013
Long-term debt, excluding current maturities12122421221012
Capital lease obligations   001
Operating lease, liability4
Liabilities, other than long-term debt12841403931
Deferred revenue and credits22221
Deferred revenue2
Due to related parties77383736  
Other liabilities3111111
Other undisclosed noncurrent liabilities 2    1
Total noncurrent liabilities:28226661611315
Total liabilities:49348876744427
Stockholders' equity
Stockholders' equity attributable to parent2413(51)(30)(2)3342
Common stock00     
Additional paid in capital344296215204202193147
Accumulated deficit(321)(283)(266)(235)(204)(160)(105)
Total stockholders' equity:2413(51)(30)(2)3342
TOTAL LIABILITIES AND EQUITY:73473746727769

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues2921181410915
Revenue, net181410915
Cost of revenue(13)(11)(11)(10)(9)(9)(11)
Cost of goods and services sold    (0)(1)(1)
Gross profit:1610851(0)4
Operating expenses(44)(30)(31)(28)(40)(48)(33)
Operating loss:(28)(20)(23)(24)(39)(49)(29)
Nonoperating income (expense)(9)(1)(8)(7)(4)(3)1
Other nonoperating income (expense)0(0)(0)(0)0(0)(0)
Interest and debt expense(1)(2)(3)(3)(3)(3)(6)
Other undisclosed income from continuing operations before equity method investments, income taxes1     6
Loss from continuing operations before equity method investments, income taxes:(37)(22)(34)(34)(46)(55)(28)
Other undisclosed income from continuing operations before income taxes  3333 
Loss from continuing operations before income taxes:(37)(22)(31)(31)(44)(52)(28)
Income tax expense(0)      
Net loss:(37)(22)(31)(31)(44)(52)(28)
Other undisclosed net income attributable to parent02     
Net loss attributable to parent:(37)(20)(31)(31)(44)(52)(28)
Preferred stock dividends and other adjustments      (1)
Net loss available to common stockholders, basic:(37)(20)(31)(31)(44)(52)(30)
Other undisclosed net loss available to common stockholders, diluted      (5)
Net loss available to common stockholders, diluted:(37)(20)(31)(31)(44)(52)(35)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(37)(22)(31)(31)(44)(52)(28)
Comprehensive loss, net of tax, attributable to parent:(37)(22)(31)(31)(44)(52)(28)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: